Healthcare provider profile · identity verified

Thant Zin, M.D.

Internal Medicine · MIAMI, OK · NPI 1013985654

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	411	113
Gabapentin	Gabapentin	312	86
Furosemide	Furosemide	295	86
Levothyroxine Sodium	Levothyroxine Sodium	292	70
Pregabalin	Pregabalin	256	40
Irbesartan	Irbesartan	239	56
Pantoprazole Sodium	Pantoprazole Sodium	219	61
Spironolactone	Spironolactone	218	57
Atorvastatin Calcium	Atorvastatin Calcium	214	64
Amlodipine Besylate	Amlodipine Besylate	197	61
Metformin Hcl	Metformin Hcl	195	50
Omeprazole	Omeprazole	195	65
Lisinopril	Lisinopril	194	51
Losartan Potassium	Losartan Potassium	193	54
Misoprostol	Misoprostol	193	51
Metoprolol Succinate	Metoprolol Succinate	192	48
Eliquis	Apixaban	188	32
Ezetimibe	Ezetimibe	176	42
Buspirone Hcl	Buspirone Hcl	157	41
Lansoprazole	Lansoprazole	148	36
Mirtazapine	Mirtazapine	129	35
Sertraline Hcl	Sertraline Hcl	129	30
Alendronate Sodium	Alendronate Sodium	127	38
Potassium Chloride	Potassium Chloride	122	37
Montelukast Sodium	Montelukast Sodium	120	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	18
Prednisone	Prednisone	115	56
Pravastatin Sodium	Pravastatin Sodium	113	28
Tamsulosin Hcl	Tamsulosin Hcl	112	30
Famotidine	Famotidine	110	33
Carvedilol	Carvedilol	105	30
Tramadol Hcl	Tramadol Hcl	104	17
Trazodone Hcl	Trazodone Hcl	103	29
Albuterol Sulfate Hfa	Albuterol Sulfate	98	24
Ozempic	Semaglutide	98	16
Clopidogrel	Clopidogrel Bisulfate	97	24
Allopurinol	Allopurinol	92	27
Jardiance	Empagliflozin	85	24
Topiramate	Topiramate	82	22
Doxycycline Hyclate	Doxycycline Hyclate	81	54
Nifedipine Er	Nifedipine	80	19
Baclofen	Baclofen	79	22
Metoprolol Tartrate	Metoprolol Tartrate	78	22
Duloxetine Hcl	Duloxetine Hcl	77	18
Tizanidine Hcl	Tizanidine Hcl	65	17
Venlafaxine Hcl Er	Venlafaxine Hcl	64	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	15
Fluticasone Propionate	Fluticasone Propionate	56	20
Azithromycin	Azithromycin	55	41
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	suppressed
Fluconazole	Fluconazole	50	33
Meloxicam	Meloxicam	50	17
Oxybutynin Chloride Er	Oxybutynin Chloride	48	11
Doxazosin Mesylate	Doxazosin Mesylate	47	13
Trulicity	Dulaglutide	47	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	46	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Glipizide Er	Glipizide	45	16
Metformin Hcl Er	Metformin Hcl	44	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	29
Hydrochlorothiazide	Hydrochlorothiazide	41	15
Cephalexin	Cephalexin	40	27
Metoclopramide Hcl	Metoclopramide Hcl	40	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	11
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Ibandronate Sodium	Ibandronate Sodium	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	11
Primidone	Primidone	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Metronidazole	Metronidazole	27	20
Mounjaro	Tirzepatide	27	suppressed
Methylprednisolone	Methylprednisolone	26	24
Farxiga	Dapagliflozin Propanediol	25	suppressed
Finasteride	Finasteride	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	11
Amoxicillin	Amoxicillin	22	17
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Cefuroxime	Cefuroxime Axetil	17	15
Colestipol Hcl	Colestipol Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Cefdinir	Cefdinir	15	13
Fentanyl	Fentanyl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error